Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease

[1]  S. Laurent,et al.  Large Artery Stiffening and Remodeling Are Independently Associated With All-Cause Mortality and Cardiovascular Events in Chronic Kidney Disease , 2012, Hypertension.

[2]  A. Dominiczak,et al.  Early pregnancy soluble E-selectin concentrations and risk of preeclampsia , 2012, Journal of hypertension.

[3]  Shang-Jyh Hwang,et al.  Brachial-ankle pulse wave velocity and rate of renal function decline and mortality in chronic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[4]  F. Ageev,et al.  Prognostic value of changes in arterial stiffness in men with coronary artery disease , 2010, Vascular health and risk management.

[5]  Rajan K. Patel,et al.  Association between proteinuria and left ventricular mass index: a cardiac MRI study in patients with chronic kidney disease. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  A. Dominiczak,et al.  Reduced LDL-cholesterol levels in patients with coronary artery disease are paralelled by improved endothelial function: An observational study in patients from 2003 and 2007 , 2010, Atherosclerosis.

[7]  Martin W. McBride,et al.  Gene expression profiling in whole blood of patients with coronary artery disease , 2010, Clinical science.

[8]  S. Kihara,et al.  Increment and impairment of adiponectin in renal failure. , 2010, Cardiovascular research.

[9]  D. Fliser,et al.  Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease , 2010, European journal of clinical investigation.

[10]  Michael J. Pencina,et al.  Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study , 2010, Circulation.

[11]  L. Ruilope,et al.  Effects of telmisartan and ramipril on adiponectin and blood pressure in patients with type 2 diabetes. , 2008, American journal of hypertension.

[12]  D. Webb,et al.  Renal function is associated with arterial stiffness and predicts outcome in patients with coronary artery disease. , 2008, QJM : monthly journal of the Association of Physicians.

[13]  A. Dominiczak,et al.  Vascular stiffness is related to superoxide generation in the vessel wall , 2008, Journal of hypertension.

[14]  A. Dominiczak,et al.  Cardiac magnetic resonance findings predict increased resource utilization in elective coronary artery bypass grafting. , 2008, Clinical science.

[15]  K. Polkinghorne,et al.  Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  C. Zoccali,et al.  Circulating E‐selectin as a risk marker in patients with end‐stage renal disease , 2007, Journal of internal medicine.

[17]  E. Mannarino,et al.  Relation Between Renal Function Within the Normal Range and Central and Peripheral Arterial Stiffness in Hypertension , 2006, Hypertension.

[18]  P. Stenvinkel,et al.  Soluble adhesion molecules in end-stage renal disease: a predictor of outcome. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  C. Falcone,et al.  Prognostic significance of plasma osteopontin levels in patients with chronic stable angina. , 2006, European heart journal.

[20]  Albert Hofman,et al.  Arterial Stiffness and Risk of Coronary Heart Disease and Stroke: The Rotterdam Study , 2006, Circulation.

[21]  A. Dominiczak,et al.  Low-Density Lipoprotein Cholesterol Determines Oxidative Stress and Endothelial Dysfunction in Saphenous Veins From Patients With Coronary Artery Disease , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[22]  D. Goldsmith,et al.  Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. , 2005, Journal of nephrology.

[23]  N. Tanaka,et al.  Brachial -- ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[24]  A. Mendez,et al.  Aortic Pressure Augmentation Predicts Adverse Cardiovascular Events in Patients With Established Coronary Artery Disease , 2005, Hypertension.

[25]  W. Tsai,et al.  Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  C. Zoccali,et al.  Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. , 2005, Journal of the American Society of Nephrology : JASN.

[27]  Sara Oliván,et al.  Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension , 2004, Journal of hypertension.

[28]  Peter Stenvinkel,et al.  The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. , 2002, Kidney international.

[29]  J. Blacher,et al.  Prognostic significance of arterial stiffness measurements in end-stage renal disease patients , 2002, Current opinion in nephrology and hypertension.

[30]  S. Laurent,et al.  Aortic Stiffness Is an Independent Predictor of Primary Coronary Events in Hypertensive Patients: A Longitudinal Study , 2002, Hypertension.

[31]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[32]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[33]  J. Blacher,et al.  Impact of aortic stiffness on survival in end-stage renal disease. , 1999, Circulation.

[34]  K. Hirokawa,et al.  Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. , 1993, The Journal of clinical investigation.

[35]  A. Jardine,et al.  Renal function and cardiovascular events: relevance of eGFR and albuminuria in patients with diabetes , 2010, Diabetologia.

[36]  A. Keech,et al.  Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study , 2010, Diabetologia.

[37]  K. Kohara,et al.  An association between decreased estimated glomerular filtration rate and arterial stiffness. , 2008, Internal medicine.

[38]  Peter Libby,et al.  Inflammation in Atherosclerosis : From Vascular Biology to Biomarker Discovery and Risk Prediction , 2007 .

[39]  A. Dominiczak,et al.  Vascular function in patients with end-stage renal disease and/or coronary artery disease: a cardiac magnetic resonance imaging study. , 2007, Kidney international.

[40]  B. Fink,et al.  A new approach for extracellular spin trapping of nitroglycerin-induced superoxide radicals both in vitro and in vivo. , 2000, Free radical biology & medicine.